title: [Apomorphine and erectile dysfunction].
abstract: Erectile dysfunction is a common disease of andrology, for which current guidelines recommend oral agents as the first-line therapy. The dopamine agonist apomorphine acts on the central control of penile erection to allow a sublingual preparation to produce a prompt response. It is not contraindicated in patients on nitrate medication for coronary artery disease. The present review describes the pharmacodynamics, action mechanism, efficacy and adverse effects of apomorphine.
authors.affiliation: Department of Urology, Renmin Hospital of Wuhan University, Wuhan , Hubei 430060, China.
authors.forename: Da-qing
authors.initials: DQ
authors.lastname: Tan
authors.forename: Yi
authors.initials: Y
authors.lastname: Yao
authors.forename: Jie
authors.initials: J
authors.lastname: Zhang
mesh_terms: D001058:Apomorphine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018491:Dopamine Agonists / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D008297:Male; D010410:Penile Erection / Q000187:drug effects
chemical_list: D018491:Dopamine Agonists; D001058:Apomorphine